207 related articles for article (PubMed ID: 35565853)
1. Biomarkers of Redox Balance Adjusted to Exercise Intensity as a Useful Tool to Identify Patients at Risk of Muscle Disease through Exercise Test.
Grillet PE; Badiou S; Lambert K; Sutra T; Plawecki M; Raynaud de Mauverger E; Brun JF; Mercier J; Gouzi F; Cristol JP
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565853
[TBL] [Abstract][Full Text] [Related]
2. Spiroergometric parameters at maximal exercise testing assessed functional respiratory impairment in asbestos-induced fibrosis.
Schneider J; Arhelger R; Funk M
Clin Respir J; 2014 Apr; 8(2):175-84. PubMed ID: 24028216
[TBL] [Abstract][Full Text] [Related]
3. Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis.
Savi D; Di Paolo M; Simmonds N; Onorati P; Internullo M; Quattrucci S; Winston B; Laveneziana P; Palange P
BMC Pulm Med; 2015 May; 15():59. PubMed ID: 25952747
[TBL] [Abstract][Full Text] [Related]
4. [Incremental stress test: comparison between protocols and cardiorespiratory reference values in healthy workers].
Carta P; Aru G
G Ital Med Lav Ergon; 2001; 23(1):5-11. PubMed ID: 11386187
[TBL] [Abstract][Full Text] [Related]
5. The association of lung function and pulmonary vasculature volume with cardiorespiratory fitness in the community.
McNeill J; Chernofsky A; Nayor M; Rahaghi FN; San Jose Estepar R; Washko G; Synn A; Vasan RS; O'Connor G; Larson MG; Ho JE; Lewis GD
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 34996832
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Attenuation of Pulmonary V'O2 Slow Component in Humans after Prolonged Endurance Training.
Zoladz JA; Majerczak J; Grassi B; Szkutnik Z; Korostyński M; Gołda S; Grandys M; Jarmuszkiewicz W; Kilarski W; Karasinski J; Korzeniewski B
PLoS One; 2016; 11(4):e0154135. PubMed ID: 27104346
[TBL] [Abstract][Full Text] [Related]
7. "Metabolic and cardiovascular response to exercise in patients with type 1 diabetes".
Turinese I; Marinelli P; Bonini M; Rossetti M; Statuto G; Filardi T; Paris A; Lenzi A; Morano S; Palange P
J Endocrinol Invest; 2017 Sep; 40(9):999-1005. PubMed ID: 28386795
[TBL] [Abstract][Full Text] [Related]
8. Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19.
Ingul CB; Edvardsen A; Follestad T; Trebinjac D; Ankerstjerne OAW; Brønstad E; Rasch-Halvorsen Ø; Aarli B; Dalen H; Nes BM; Lerum TV; Einvik G; Stavem K; Skjørten I
Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36137587
[TBL] [Abstract][Full Text] [Related]
9. Whole-body and muscle responses to aerobic exercise training and withdrawal in ageing and COPD.
Latimer LE; Constantin-Teodosiu D; Popat B; Constantin D; Houchen-Wolloff L; Bolton CE; Steiner MC; Greenhaff PL
Eur Respir J; 2022 May; 59(5):. PubMed ID: 34588196
[TBL] [Abstract][Full Text] [Related]
10. Exercise efficiency impairment in metabolic myopathies.
Noury JB; Zagnoli F; Petit F; Marcorelles P; Rannou F
Sci Rep; 2020 May; 10(1):8765. PubMed ID: 32472082
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for severe COVID-19.
Noureddine S; Roux-Claudé P; Laurent L; Ritter O; Dolla P; Karaer S; Claudé F; Eberst G; Westeel V; Barnig C
BMC Pulm Med; 2023 Jan; 23(1):13. PubMed ID: 36635717
[TBL] [Abstract][Full Text] [Related]
12. Peak V'O
Hein S; Aus Dem Siepen F; Bauer R; Katus HA; Kristen AV
Amyloid; 2018 Sep; 25(3):167-173. PubMed ID: 30193539
[TBL] [Abstract][Full Text] [Related]
13. Body mass and V'O
Zoladz JA; Zapart-Bukowska J; Grandys M; Szkutnik Z; Grassi B; Majerczak J
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085515
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary testing in adult patients with β-thalassemia major in comparison to healthy subjects.
Piatti G; Giuditta M; Consonni D; Cassinerio E; Cappellini MD
Ann Hematol; 2022 Nov; 101(11):2445-2452. PubMed ID: 36100732
[TBL] [Abstract][Full Text] [Related]
15. Comparison of V'O2 kinetics in upright and supine position.
Hoffmann U; Essfeld D; Stegemann J; Schutze H
Acta Astronaut; 1991; 23():135-7. PubMed ID: 11537115
[TBL] [Abstract][Full Text] [Related]
16. Reliability of maximum oxygen uptake in cardiopulmonary exercise testing with continuous laryngoscopy.
Engan M; Hammer IJ; Bekken M; Halvorsen T; Fretheim-Kelly ZL; Vollsæter M; Bovim LPV; Røksund OD; Clemm H
ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33614778
[TBL] [Abstract][Full Text] [Related]
17. Prediction of maximal oxygen uptake from 6-min walk test in pulmonary hypertension.
Appenzeller P; Gautschi F; Müller J; Lichtblau M; Saxer S; Schneider SR; Schwarz EI; Ulrich S
ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35747228
[TBL] [Abstract][Full Text] [Related]
18. Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies.
Chaussain M; Camus F; Defoligny C; Eymard B; Fardeau M
Eur J Med; 1992 Dec; 1(8):457-63. PubMed ID: 1341204
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation.
Skjørten I; Ankerstjerne OAW; Trebinjac D; Brønstad E; Rasch-Halvorsen Ø; Einvik G; Lerum TV; Stavem K; Edvardsen A; Ingul CB
Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34210791
[TBL] [Abstract][Full Text] [Related]
20. Gas exchange response to exercise in patients with chronic heart failure.
Bellone A; Rusconi F; Frisinghelli A; Aliprandi P; Castelli C; Confalonieri M; Palange P
Monaldi Arch Chest Dis; 1999 Feb; 54(1):3-6. PubMed ID: 10218364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
